+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AAV Production Service Market - Global Forecast 2026-2032- Product Image
AAV Production Service Market - Global Forecast 2026-2032- Product Image
Sale

AAV Production Service Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6148162
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The AAV Production Service Market is projected to reach USD 269.03 Million in 2026. It is expected to continue growing at a CAGR of 15.45%, reaching USD 635.32 Million by 2032.

AAV Production Services: Executive Overview

Adeno-associated virus (AAV) production services support the development and manufacture of gene therapies by providing process development, vector production, purification, analytical testing, and related regulatory support. The field is moving from research-scale experimentation toward more reproducible, quality-focused manufacturing systems. Demand is shaped by clinical progress in gene therapy, increasing expectations for product comparability, and the need to manage complex supply chains while preserving vector potency and safety.

Manufacturing Shifts Are Reshaping AAV Production

AAV production is being transformed by stronger emphasis on scalability, process consistency, and control of critical quality attributes. Service providers and developers are prioritizing platform processes, improved upstream productivity, more efficient purification, closed or automated operations, and fit-for-purpose analytical methods. At the same time, regulatory expectations are encouraging earlier process characterization, clearer raw-material controls, and better alignment between development, clinical manufacturing, and commercial readiness.

Artificial Intelligence Is Improving Process and Quality Decisions

Artificial intelligence and machine learning are increasingly relevant to AAV production through experimental design, process monitoring, batch-data analysis, and prediction of yield or impurity trends. These tools can help identify relationships among cell culture conditions, transfection parameters, purification steps, and product attributes. Their practical value depends on high-quality training data, standardized data structures, validated models, and human oversight. AI should therefore complement, rather than replace, laboratory evidence, process understanding, and regulatory validation.

Regional Dynamics Reflect Different Manufacturing and Regulatory Priorities

North America combines mature biotechnology infrastructure with strong clinical-development activity and demand for integrated development-to-manufacturing services. Europe emphasizes quality systems, regulatory alignment, and cross-border manufacturing coordination. Asia-Pacific is strengthening bioprocessing capacity, technical talent, and domestic gene-therapy ecosystems. Latin America is developing specialized capabilities while relying on selective partnerships and technology transfer. The Middle East is investing in advanced healthcare and biomanufacturing infrastructure, whereas Africa remains focused on building foundational capacity, workforce skills, and access-oriented partnerships. Across all regions, reliable analytics, cold-chain readiness, and regulatory expertise remain important differentiators.

Economic and Strategic Groups Shape Service Requirements

ASEAN economies are strengthening regional biomanufacturing links and may benefit from interoperable quality systems and workforce development. BRICS members represent diverse capabilities, ranging from established research and manufacturing bases to emerging infrastructure, making technology transfer and regulatory coordination important. The European Union benefits from a connected regulatory and scientific environment, although cross-border execution still requires careful coordination. G7 countries generally emphasize advanced process control, clinical quality, and supply-chain resilience. GCC states are building healthcare and life-science capabilities through investment and partnerships. NATO members may place additional emphasis on secure, resilient, and domestically accessible biomanufacturing supply chains.

Country-Level Capabilities Vary Across Research, Manufacturing, and Regulation

The United States and Canada have strong gene-therapy research, clinical, and manufacturing ecosystems. Germany, France, Italy, Spain, and the United Kingdom contribute established biotechnology, pharmaceutical, and regulatory capabilities within a closely connected European landscape. China is expanding domestic biomanufacturing and translational research, while Japan and South Korea combine advanced life-science infrastructure with growing interest in regenerative and genetic medicines. India is developing cost-conscious bioprocessing, analytical, and clinical capabilities. Australia supports specialist research and clinical networks. Brazil and Mexico are building regional capacity, with opportunities linked to local manufacturing, partnerships, and technology transfer. Russia retains scientific and industrial capabilities but faces constraints associated with international collaboration and access to selected technologies.

Practical Priorities for AAV Production Service Leaders

Industry leaders should build platform processes without compromising product-specific characterization, and should connect development, analytical, quality, and regulatory teams from the outset. They should qualify critical raw materials, establish robust supplier controls, and design manufacturing networks with contingency options. Investment in high-throughput analytics, automation, and validated data systems can improve decision speed and batch comparability. Leaders should also define clear technology-transfer packages, strengthen workforce training, and select regional partners according to demonstrated quality performance rather than geographic reach alone. AI initiatives should begin with narrowly defined, measurable use cases supported by governance, traceability, and expert review.

Research Methodology for the AAV Production Service Assessment

This executive summary uses a structured assessment of the AAV production-service value chain, including upstream production, downstream purification, analytical characterization, quality control, process development, technology transfer, and regulatory support. The analysis considers documented industry practices, manufacturing requirements, regional life-science infrastructure, policy environments, and technology trends. Regional, group, and country observations are presented qualitatively to avoid unsupported numerical claims. Interpretation focuses on verifiable operational drivers, capability differences, and strategic implications rather than market estimates, market shares, or forecasts.

AAV Services Are Moving Toward Integrated, Data-Driven Execution

AAV production services are becoming more integrated as developers seek dependable transitions from early research through clinical and later-stage manufacturing. Competitive strength will increasingly depend on reproducible processes, strong analytics, regulatory readiness, resilient supply chains, and effective technology transfer. Organizations that combine scientific depth with disciplined quality systems and responsible use of automation and AI will be better positioned to support the evolving gene-therapy ecosystem across diverse regions and country environments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. AAV Production Service Market, by Scale
7.1. Introduction
7.2. Clinical
7.3. Commercial
7.4. Preclinical
8. AAV Production Service Market, by Service Model
8.1. Introduction
8.2. Analytical
8.3. Downstream
8.4. Upstream
9. AAV Production Service Market, by Application
9.1. Introduction
9.2. Gene Therapy
9.2.1. Neurology
9.2.2. Oncology
9.2.3. Ophthalmology
9.2.4. Rare Diseases
9.3. Research Tools
9.4. Vaccines
10. AAV Production Service Market, by Cell Line
10.1. Introduction
10.2. Hek 293
10.3. Sf9
11. AAV Production Service Market, by Virus Serotype
11.1. Introduction
11.2. Aav2
11.3. Aav8
11.4. Aav9
12. AAV Production Service Market, by Vector Format
12.1. Introduction
12.2. Self-Complementary
12.3. Single-Stranded
13. AAV Production Service Market, by Purification Method
13.1. Introduction
13.2. Chromatography
13.3. Filtration
13.4. Ultracentrifugation
14. AAV Production Service Market, by End User
14.1. Introduction
14.2. Academic Institutes
14.3. Biotechnology Companies
14.4. Contract Research Organizations
14.5. Pharmaceutical Companies
14.5.1. Generic Pharma
14.5.2. Large Pharma
14.5.3. Mid-Sized Pharma
15. AAV Production Service Market, by Region
15.1. Introduction
15.2. Asia-Pacific
15.3. North America
15.4. Latin America
15.5. Europe
15.6. Middle East
15.7. Africa
16. AAV Production Service Market, by Group
16.1. Introduction
16.2. ASEAN
16.3. GCC
16.4. European Union
16.5. BRICS
16.6. G7
16.7. NATO
17. AAV Production Service Market, by Country
17.1. Introduction
17.2. United States
17.3. Canada
17.4. Mexico
17.5. Brazil
17.6. United Kingdom
17.7. Germany
17.8. France
17.9. Russia
17.10. Italy
17.11. Spain
17.12. China
17.13. India
17.14. Japan
17.15. Australia
17.16. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. Market Concentration Analysis, 2025
18.2.1. Concentration Ratio (CR)
18.2.2. Herfindahl Hirschman Index (HHI)
18.3. Recent Developments & Impact Analysis, 2025
18.4. Product Portfolio Analysis, 2025
18.5. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Aldevron LLC
19.2. Bluebird Bio, Inc.
19.3. Catalent, Inc.
19.4. Cell and Gene Therapy Catapult
19.5. Charles River Laboratories International, Inc.
19.6. Charles River Laboratories International, Inc.
19.7. FUJIFILM Diosynth Biotechnologies
19.8. Genezen Laboratories, Inc.
19.9. Lonza Group Ltd.
19.10. Merck KGaA
19.11. Novasep Holding SAS
19.12. Oxford Biomedica plc
19.13. Paragon Bioservices, Inc.
19.14. Samsung Biologics Co., Ltd.
19.15. Thermo Fisher Scientific Inc.
19.16. Thermo Fisher Scientific Inc.
19.17. uniQure N.V.
19.18. VGXI, Inc.
19.19. Vigene Biosciences
19.20. WuXi Biologics Inc.
20. Key Experts
LIST OF FIGURES
FIGURE 1. Global AAV Production Service Market, Years Considered for the Study
FIGURE 2. Global AAV Production Service Market, Research Design
FIGURE 3. Global AAV Production Service Market, Research Framework
FIGURE 4. Global AAV Production Service Market, Data Triangulation
FIGURE 5. Global AAV Production Service Market Size, 2017-2032 (USD Million)
FIGURE 6. Global AAV Production Service Market Size, by Scale, 2025 vs 2032 (%)
FIGURE 7. Global AAV Production Service Market Size, by Scale, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global AAV Production Service Market Size, by Service Model, 2025 vs 2032 (%)
FIGURE 9. Global AAV Production Service Market Size, by Service Model, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global AAV Production Service Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global AAV Production Service Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global AAV Production Service Market Size, by Cell Line, 2025 vs 2032 (%)
FIGURE 13. Global AAV Production Service Market Size, by Cell Line, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global AAV Production Service Market Size, by Virus Serotype, 2025 vs 2032 (%)
FIGURE 15. Global AAV Production Service Market Size, by Virus Serotype, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global AAV Production Service Market Size, by Vector Format, 2025 vs 2032 (%)
FIGURE 17. Global AAV Production Service Market Size, by Vector Format, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global AAV Production Service Market Size, by Purification Method, 2025 vs 2032 (%)
FIGURE 19. Global AAV Production Service Market Size, by Purification Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global AAV Production Service Market Size, by End User, 2025 vs 2032 (%)
FIGURE 21. Global AAV Production Service Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global AAV Production Service Market Size, by Region, 2025 vs 2032 (%)
FIGURE 23. Global AAV Production Service Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global AAV Production Service Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global AAV Production Service Market Size, by Country, 2025 vs 2032 (%)
FIGURE 26. Global AAV Production Service Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global AAV Production Service Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global AAV Production Service Market Segmentation & Coverage
TABLE 2. Global AAV Production Service Market Size, 2017-2032 (USD Million)
TABLE 3. Global AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 4. Global Clinical Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Clinical Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Clinical Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Commercial Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Commercial Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Commercial Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Preclinical Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Preclinical Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Preclinical Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 14. Global Analytical Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Analytical Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Analytical Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Downstream Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Downstream Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Downstream Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Upstream Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Upstream Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Upstream Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 24. Global Gene Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Gene Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Gene Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Ophthalmology Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Ophthalmology Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Ophthalmology Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Rare Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Rare Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Rare Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Research Tools Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Research Tools Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Research Tools Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 46. Global Hek 293 Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Hek 293 Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Hek 293 Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Sf9 Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Sf9 Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Sf9 Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 53. Global Aav2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Aav2 Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Aav2 Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Aav8 Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Aav8 Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Aav8 Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Aav9 Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Aav9 Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Aav9 Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 63. Global Self-Complementary Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Self-Complementary Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Self-Complementary Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Single-Stranded Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Single-Stranded Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Single-Stranded Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 70. Global Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Filtration Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Filtration Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Filtration Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Ultracentrifugation Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Ultracentrifugation Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Ultracentrifugation Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. Global Academic Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Academic Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Academic Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Generic Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Generic Pharma Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Generic Pharma Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Large Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Large Pharma Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Large Pharma Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Mid-Sized Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Mid-Sized Pharma Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Mid-Sized Pharma Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global AAV Production Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific AAV Production Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 113. North America AAV Production Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. North America AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 115. North America AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 116. North America AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. North America AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 118. North America AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 119. North America AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 120. North America AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 121. North America AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 122. North America AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. North America AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 124. Latin America AAV Production Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Latin America AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 126. Latin America AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 127. Latin America AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. Latin America AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 129. Latin America AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 130. Latin America AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 131. Latin America AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 132. Latin America AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 133. Latin America AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. Latin America AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 135. Europe AAV Production Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Europe AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 137. Europe AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 138. Europe AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 139. Europe AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 140. Europe AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 141. Europe AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 142. Europe AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 143. Europe AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 144. Europe AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Europe AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 146. Middle East AAV Production Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Middle East AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 148. Middle East AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 149. Middle East AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. Middle East AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 151. Middle East AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 152. Middle East AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 153. Middle East AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 154. Middle East AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 155. Middle East AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. Middle East AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 157. Africa AAV Production Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Africa AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 159. Africa AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 160. Africa AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. Africa AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 162. Africa AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 163. Africa AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 164. Africa AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 165. Africa AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 166. Africa AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. Africa AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 168. Global AAV Production Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. ASEAN AAV Production Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. ASEAN AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 171. ASEAN AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 172. ASEAN AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. ASEAN AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 174. ASEAN AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 175. ASEAN AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 176. ASEAN AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 177. ASEAN AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 178. ASEAN AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. ASEAN AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 180. GCC AAV Production Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. GCC AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 182. GCC AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 183. GCC AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. GCC AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 185. GCC AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 186. GCC AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 187. GCC AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 188. GCC AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 189. GCC AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. GCC AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 191. European Union AAV Production Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. European Union AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 193. European Union AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 194. European Union AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. European Union AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 196. European Union AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 197. European Union AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 198. European Union AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 199. European Union AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 200. European Union AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. European Union AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 202. BRICS AAV Production Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. BRICS AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 204. BRICS AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 205. BRICS AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. BRICS AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 207. BRICS AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 208. BRICS AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 209. BRICS AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 210. BRICS AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 211. BRICS AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. BRICS AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 213. G7 AAV Production Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 214. G7 AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 215. G7 AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 216. G7 AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. G7 AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 218. G7 AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 219. G7 AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 220. G7 AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 221. G7 AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 222. G7 AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. G7 AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 224. NATO AAV Production Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 225. NATO AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 226. NATO AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 227. NATO AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. NATO AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 229. NATO AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 230. NATO AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 231. NATO AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 232. NATO AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 233. NATO AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. NATO AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 235. Global AAV Production Service Market Size, by Country, 2017-2032 (USD Million)
TABLE 236. United States AAV Production Service Market Size, 2017-2032 (USD Million)
TABLE 237. United States AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 238. United States AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 239. United States AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. United States AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 241. United States AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 242. United States AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 243. United States AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 244. United States AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 245. United States AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. United States AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 247. Canada AAV Production Service Market Size, 2017-2032 (USD Million)
TABLE 248. Canada AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 249. Canada AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 250. Canada AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. Canada AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 252. Canada AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 253. Canada AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 254. Canada AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 255. Canada AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 256. Canada AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. Canada AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 258. Mexico AAV Production Service Market Size, 2017-2032 (USD Million)
TABLE 259. Mexico AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 260. Mexico AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 261. Mexico AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. Mexico AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 263. Mexico AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 264. Mexico AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 265. Mexico AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 266. Mexico AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 267. Mexico AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. Mexico AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 269. Brazil AAV Production Service Market Size, 2017-2032 (USD Million)
TABLE 270. Brazil AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 271. Brazil AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 272. Brazil AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. Brazil AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 274. Brazil AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 275. Brazil AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 276. Brazil AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 277. Brazil AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 278. Brazil AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. Brazil AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 280. United Kingdom AAV Production Service Market Size, 2017-2032 (USD Million)
TABLE 281. United Kingdom AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 282. United Kingdom AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 283. United Kingdom AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 284. United Kingdom AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 285. United Kingdom AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 286. United Kingdom AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 287. United Kingdom AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 288. United Kingdom AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 289. United Kingdom AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. United Kingdom AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 291. Germany AAV Production Service Market Size, 2017-2032 (USD Million)
TABLE 292. Germany AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 293. Germany AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 294. Germany AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 295. Germany AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 296. Germany AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 297. Germany AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 298. Germany AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 299. Germany AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 300. Germany AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 301. Germany AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 302. France AAV Production Service Market Size, 2017-2032 (USD Million)
TABLE 303. France AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 304. France AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 305. France AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 306. France AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 307. France AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 308. France AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 309. France AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 310. France AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 311. France AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 312. France AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 313. Russia AAV Production Service Market Size, 2017-2032 (USD Million)
TABLE 314. Russia AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 315. Russia AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 316. Russia AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 317. Russia AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 318. Russia AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 319. Russia AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 320. Russia AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 321. Russia AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 322. Russia AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. Russia AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 324. Italy AAV Production Service Market Size, 2017-2032 (USD Million)
TABLE 325. Italy AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 326. Italy AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 327. Italy AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 328. Italy AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 329. Italy AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 330. Italy AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 331. Italy AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 332. Italy AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 333. Italy AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 334. Italy AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 335. Spain AAV Production Service Market Size, 2017-2032 (USD Million)
TABLE 336. Spain AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 337. Spain AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 338. Spain AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 339. Spain AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 340. Spain AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 341. Spain AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 342. Spain AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 343. Spain AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 344. Spain AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 345. Spain AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 346. China AAV Production Service Market Size, 2017-2032 (USD Million)
TABLE 347. China AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 348. China AAV Production Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 349. China AAV Production Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 350. China AAV Production Service Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 351. China AAV Production Service Market Size, by Cell Line, 2017-2032 (USD Million)
TABLE 352. China AAV Production Service Market Size, by Virus Serotype, 2017-2032 (USD Million)
TABLE 353. China AAV Production Service Market Size, by Vector Format, 2017-2032 (USD Million)
TABLE 354. China AAV Production Service Market Size, by Purification Method, 2017-2032 (USD Million)
TABLE 355. China AAV Production Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 356. China AAV Production Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 357. India AAV Production Service Market Size, 2017-2032 (USD Million)
TABLE 358. India AAV Production Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 359. India AAV Production Service Market Size, b

Companies Mentioned

  • Aldevron LLC
  • Bluebird Bio, Inc.
  • Catalent, Inc.
  • Cell and Gene Therapy Catapult
  • Charles River Laboratories International, Inc.
  • Charles River Laboratories International, Inc.
  • FUJIFILM Diosynth Biotechnologies
  • Genezen Laboratories, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Novasep Holding SAS
  • Oxford Biomedica plc
  • Paragon Bioservices, Inc.
  • Samsung Biologics Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc.
  • uniQure N.V.
  • VGXI, Inc.
  • Vigene Biosciences
  • WuXi Biologics Inc.

Related Topics

Related Reports

Viral Transduction Enhancer Market - Global Forecast 2026-2032 - Product Image

Viral Transduction Enhancer Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Cell & Gene Therapy Biomanufacturing CDMO Market - Global Forecast 2026-2032 - Product Image

Cell & Gene Therapy Biomanufacturing CDMO Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Viral Vector Bioanalytical Testing Services Market Size, Share & Trends Analysis Report by Test, Viral Vector, Development Stage, End-use, Region, and Segment Forecasts, 2026-2033 - Product Image

Viral Vector Bioanalytical Testing Services Market Size, Share & Trends Analysis Report by Test, Viral Vector, Development Stage, End-use, Region, and Segment Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Viral Capsid Development Market Size, Share & Trends Analysis Report by Type, Application, End-use, Region, and Segment Forecasts, 2026-2033 - Product Image

Viral Capsid Development Market Size, Share & Trends Analysis Report by Type, Application, End-use, Region, and Segment Forecasts, 2026-2033

  • Report
  • 120 Pages
  • Global
From
Biotechnology for the Non-Biotechnologist (November 30, 2026 December 4, 2026) - Product Image

Biotechnology for the Non-Biotechnologist (November 30, 2026 December 4, 2026)

  • Training
  • 5 Days
  • Global
Copyright © 2002-2026 Research and Markets. All Rights Reserved.